Tr1x

Tr1X is pioneering a revolutionary category of regulatory T cell-based products aimed at curing autoimmune and inflammatory diseases, with the potential to significantly improve the lives of patients.

Country

USA

Website

tr1x.bio

Founded

2018

Social

Source of information:

www.tr1x.bio/

Add to My List

Key Executives

Bill Lis

Chief Executive Officer

Maria Grazia Roncarolo, MD

Co-founder, President and Head of R&D

David de Vries, MPhil

Co-founder, Chief Operating Officer

Industries

Med Tech

Add Your Company

Disclaimer

The content of this website is not directed at or intended for persons in the United Kingdom or any other jurisdiction where the provision of the website or services would breach any applicable law or registration or would require any registration or license in any such jurisdiction. The content of this website should not be regarded as an invitation or inducement to engage in investment activity, to any person in the United Kingdom and investment opportunities described on this website are not intended to be acted upon by any persons in the United Kingdom.